FEXOFENADINE HYDROCHLORIDE ALLERGY Drug Patent Profile
✉ Email this page to a colleague
When do Fexofenadine Hydrochloride Allergy patents expire, and what generic alternatives are available?
Fexofenadine Hydrochloride Allergy is a drug marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Hetero Labs Ltd V, Rising, Sciegen Pharms Inc, Sun Pharm Inds, Teva, Unique, and Wockhardt. and is included in ten NDAs.
The generic ingredient in FEXOFENADINE HYDROCHLORIDE ALLERGY is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and one suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fexofenadine Hydrochloride Allergy
A generic version of FEXOFENADINE HYDROCHLORIDE ALLERGY was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.
Summary for FEXOFENADINE HYDROCHLORIDE ALLERGY
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 86 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Clinical Trials: | 78 |
| Patent Applications: | 1,705 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | FEXOFENADINE HYDROCHLORIDE ALLERGY at DailyMed |
Recent Clinical Trials for FEXOFENADINE HYDROCHLORIDE ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Dhaka Medical College | Phase 2/Phase 3 |
| Opella Healthcare Group SAS, a Sanofi Company | Phase 3 |
| Eurofarma Laboratorios S.A. | Phase 3 |
Pharmacology for FEXOFENADINE HYDROCHLORIDE ALLERGY
| Drug Class | Histamine-1 Receptor Antagonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for FEXOFENADINE HYDROCHLORIDE ALLERGY
US Patents and Regulatory Information for FEXOFENADINE HYDROCHLORIDE ALLERGY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | FEXOFENADINE HYDROCHLORIDE ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 202039-002 | Nov 19, 2014 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Wockhardt | FEXOFENADINE HYDROCHLORIDE ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 079112-004 | Feb 8, 2012 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hetero Labs Ltd V | FEXOFENADINE HYDROCHLORIDE ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 204097-002 | Aug 19, 2016 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Ltd | FEXOFENADINE HYDROCHLORIDE ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 076502-008 | Apr 12, 2011 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
